Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Although combination therapy with immune checkpoint inhibitors (ICIs) provides a promising efficacy in multiple cancers, their use is facing challenges for a high incidence of adverse effects. This meta-analysis was conducted to compare the risks of organ-specific immune-related adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Da, Lijun, Teng, Yuanjun, Wang, Na, Zaguirre, Karen, Liu, Yating, Qi, Yali, Song, Feixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002539/
https://www.ncbi.nlm.nih.gov/pubmed/32082164
http://dx.doi.org/10.3389/fphar.2019.01671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002539/
https://www.ncbi.nlm.nih.gov/pubmed/32082164
http://dx.doi.org/10.3389/fphar.2019.01671

Ejemplares similares